Pilot study of cisplatin, 5-fluorouracil, and a taxane (TPF) for advanced squamous cell carcinoma (SCC) of the penis.

被引：5
作者：
Salvioni, R. [1 ]
Nicolai, N. [1 ]
Piva, L. [1 ]
Catanzaro, M. [1 ]
Torelli, T. [1 ]
Biasoni, D. [1 ]
Stagni, S. [1 ]
Milani, A. [1 ]
Necchi, A. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.4639
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4639
引用
收藏
页数：1
相关论文
共 50 条
  • [41] TREATMENT OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK WITH CISPLATIN AND 5-FLUOROURACIL
    AMREIN, PC
    WIETZMAN, SA
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (12) : 1632 - 1639
  • [42] Microarray gene expression analysis of chemosensitivity for docetaxel, cisplatin and 5-fluorouracil (TPF) combined chemotherapeutic regimen in hypopharyngeal squamous cell carcinoma
    Lian, Meng
    Wang, Haizhou
    Fang, Jugao
    Zhai, Jie
    Wang, Ru
    Shen, Xixi
    Yang, Yifan
    Ma, Zhihong
    Liu, Honggang
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (03) : 204 - +
  • [43] CISPLATIN, HIGH-DOSE FOLINIC ACID AND 5-FLUOROURACIL IN SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS - A PILOT-STUDY
    ZANIBONI, A
    SIMONCINI, E
    TONINI, G
    PEZZOLA, D
    FARFAGLIA, R
    LANCINI, GP
    MARPICATI, P
    MONTINI, E
    MARINI, G
    CHEMIOTERAPIA, 1987, 6 (06): : 387 - 389
  • [44] Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus
    Feliu, J
    Baron, MG
    Giron, CG
    Espinosa, E
    Vicent, JM
    Navarro, JG
    Berrocal, A
    Ordonez, A
    Vilches, Y
    deCastro, J
    Diaz, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (06): : 577 - 580
  • [45] Docetaxol 5-Fluorouracil, Cisplatin versus Epirubicin, 5-Fluorouracil, Cisplatin for advanced gastric carcinoma: Preliminary report
    Sadighi, Sanambar
    Mohagheghi, M. A.
    Raafat, J.
    ANNALS OF ONCOLOGY, 2004, 15 : 235 - 235
  • [46] Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Hideaki Katori
    Mamoru Tsukuda
    Kiichi Watai
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 399 - 406
  • [47] Feasibility of induction docetaxel, cisplatin, 5-fluorouracil cetuximab (TPF-C) followed by concurrent cetuximab radiotherapy for locally advanced head and neck squamous cell carcinoma
    Charalambakis, Nikolaos
    Kouloulias, Vassilis
    Vaja, Helena
    Pectasides, Dimitrios
    Rampias, Theodoros
    Economopoulos, Theofanis
    Katsaounis, Panagiotis
    Siolos, Spiros
    Bartzi, Valentina
    Perisanidis, Christos
    Laschos, Konstantinos
    Maragoudakis, Pavlos
    Proikas, Konstantinos
    Papadimitriou, Nikolaos
    Papadogeorgakis, Nikolaos
    Georgopoulou, Helen
    Zygogianni, Anna
    Artopoulou, Ioli
    Pappa, Eleni
    Dimitriadis, George
    Psyrri, Amanda
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [48] 5-fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma - A multicentre randomised controlled trial
    Levard, H
    Pouliquen, X
    Hay, JM
    Fingerhut, A
    Langlois-Zantain, O
    Huguier, M
    Lozach, P
    Testart, J
    EUROPEAN JOURNAL OF SURGERY, 1998, 164 (11) : 849 - 857
  • [49] Nimotuzumab plus chemotherapy with docetaxel, cisplatin, 5-fluorouracil for locally advanced head and neck squamous cell carcinoma: A clinical study
    Wang, Xing
    Gu, Jianmin
    Shao, Cuiling
    Han, Kun
    Meng, Jian
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (02) : 312 - 316
  • [50] DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma
    Kim, S.
    Jary, M.
    Mansi, L.
    Benzidane, B.
    Cazorla, A.
    Demarchi, M.
    Nguyen, T.
    Kaliski, A.
    Delabrousse, E.
    Bonnetain, F.
    Letondal, P.
    Bosset, J. F.
    Valmary-Degano, S.
    Borg, C.
    ANNALS OF ONCOLOGY, 2013, 24 (12) : 3045 - 3050
12345